Zachary Cargill
About Zachary Cargill
Zachary Cargill is a Research Associate at Dyno Therapeutics in Cambridge, Massachusetts, with a background in cellular and molecular biology from Northeastern University.
Company
Zachary Cargill is currently working at Dyno Therapeutics as a Research Associate. Dyno Therapeutics is located in Cambridge, Massachusetts, United States. The company specializes in gene therapy and uses a platform to optimize adeno-associated virus (AAV) vectors.
Title
Zachary Cargill holds the position of Research Associate at Dyno Therapeutics. His role involves a range of research activities centered around gene therapy and related technologies, contributing to the development of next-generation therapeutics.
Education and Expertise
Zachary Cargill studied Cell/Cellular and Molecular Biology at Northeastern University, earning his degree in the field over the course of five years from 2014 to 2019. His studies have equipped him with extensive knowledge in cellular biology, molecular mechanisms, and biotechnological applications.
Professional Background
Zachary Cargill has held multiple research-focused positions in the biotechnology sector. Prior to his current role at Dyno Therapeutics, he worked as a Research Associate at Invaio Sciences, Senda Biosciences, and Synlogic, Inc. His experience also includes roles at Ferris Development LLC and co-op positions at Synlogic Therapeutics and Tufts Medical Center. His cumulative work experience spans various aspects of therapeutic research and development.
Research Contributions
Throughout his career, Zachary Cargill has contributed to various research projects. He has designed and generated B. subtilis and P. luminescens strains to enhance longevity and efficacy in harsh environments. He also developed a pipeline for testing new platform chassis and bioactives before deployment in bioassays. Additionally, he employed computational design software to optimize heterologous nematode toxin expression in E. coli and piloted various RNA isolation and quantification methods for implementation in downstream assays.